Press release
United States Neurodegenerative Disease Therapeutics Market Outlook 2025-2033: Navigating 9.8% CAGR with Focus on Oral Routes, North America Dominance, UCB Pharma EU Launches, and Pipeline in Monoclonal Antibodies, Immunomodulators
Neurodegenerative Disease Therapeutics Market
According to DataM Intelligence has published a new research report on "Neurodegenerative Disease Therapeutics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
📌 Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurodegenerative-disease-therapeutics-market?rk
➣ Recent Developments:
United States: Recent Industry Developments
✅ In August 2025, Biogen launched its next-generation Alzheimer's therapeutics targeting amyloid and tau proteins, aiming to slow disease progression in early-stage patients.
✅ In July 2025, Roche expanded its Parkinson's disease therapy portfolio with innovative monoclonal antibodies and small molecules in clinical trials across the U.S.
✅ In June 2025, Eli Lilly partnered with U.S. research institutions to advance novel neuroprotective agents for ALS and multiple sclerosis, emphasizing disease-modifying approaches.
Europe: Recent Industry Developments
✅ In July 2025, Novartis deployed gene therapy and small-molecule therapeutics for neurodegenerative diseases across EU clinical programs.
✅ In June 2025, UCB Pharma launched next-generation therapies for Alzheimer's and Parkinson's disease in European markets, focusing on symptomatic and disease-modifying effects.
✅ In May 2025, Axsome Therapeutics partnered with European research centers to accelerate clinical trials for novel CNS therapeutics, including depression and neurodegenerative indications.
☛ Neurodegenerative Disease Therapeutics Market Trends:
Technological Advancements: Innovations in gene therapy, biologics, monoclonal antibodies, and disease-modifying drugs are creating new treatment opportunities. AI and bioinformatics are also accelerating drug discovery, target validation, and clinical trial optimization.
Rising Disease Burden: Increasing aging populations worldwide and higher incidence of Alzheimer's and Parkinson's disease are major drivers for therapeutic development and market expansion.
Pipeline Expansion: A growing number of clinical trials focusing on disease-modifying therapies is fueling investment and boosting market growth prospects.
Regional Insights: North America dominates due to strong research infrastructure, regulatory support, and high healthcare spending. Asia-Pacific is emerging rapidly, supported by aging populations, government healthcare initiatives, and growing biotech R&D.
➣ Top Industry Players:
AbbVie Inc., Amneal Pharmaceuticals LLC., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, Merck KGaA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Ltd., Orion Corporation.
📌 Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=neurodegenerative-disease-therapeutics-market?rk
➣ Key Segments:
By Drug Class: Dopamine Agonists | Decarboxylase Inhibitors | Cholinesterase Inhibitors | Immunomodulators | Others
By Disease Type: Parkinson's Disease | Amyotrophic Lateral Sclerosis | Alzheimer's Disease | Huntington Disease | Others
By Route of Administration: Oral | Injection | Transdermal
📌 Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurodegenerative-disease-therapeutics-market?rk
📌 Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/neurodegenerative-disease-therapeutics-market?rk
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
☛ Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?rk
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Neurodegenerative Disease Therapeutics Market Outlook 2025-2033: Navigating 9.8% CAGR with Focus on Oral Routes, North America Dominance, UCB Pharma EU Launches, and Pipeline in Monoclonal Antibodies, Immunomodulators here
News-ID: 4298722 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Femtech Market to Reach US$ 112.30 Billion by 2033, Driven by Rising Awareness o …
The Global Femtech Market reached US$ 38.90 billion in 2024 and is expected to reach US$ 112.30 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.
According to DataM Intelligence has published a new research report on "Femtech Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.…
United States Petrochemicals Market Expected to Grow at 5.8% CAGR Through 2031, …
Leander, Texas and Tokyo, Japan - Jan.09.2026,As per DataM intelligence research report "Petrochemicals market size is estimated to reach USD million by 2031, growing at a CAGR of 6% during the forecast period 2024-2031." Rising demand for plastics, synthetic fibers, and specialty chemicals, coupled with expanding end-use industries and capacity additions in Asia, continues to drive the petrochemicals sector despite energy transition pressures.
Download your exclusive sample report today: (corporate email…
Quantum Chip Market to Skyrocket to US$ 4.96 Billion by 2031 at 52.6% CAGR | Top …
Global Quantum Chip Market reached US$ 168.7 Million in 2023 and is expected to reach US$ 4960.8 Million by 2031, growing with a CAGR of 52.6% during the forecast period 2024-2031.
According to DataM Intelligence has published a new research report on "Quantum Chip Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and…
United States EV Charging Cable Market Projected to Reach US$ 3.2 Billion by 203 …
Leander, Texas and Tokyo, Japan - Jan.09.2026,As per DataM intelligence research report "The EV Charging Cable Market reached US$ 1.56 billion in 2024 and is expected to reach US$ 8.50 billion by 2033, growing at a CAGR of 20.7% during the forecast period 2025-2033." Rising electric vehicle adoption, fast-charging infrastructure expansion, and innovations in durable, high power cables are propelling demand for advanced EV charging solutions.
Download your exclusive sample report…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
